ArticleExperimental hematology & oncology2023

Molecular correlation of response to pyrotinib in advanced NSCLC with HER2 mutation: biomarker analysis from two phase II trials.

Shiqi Mao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.